Daniel He

Daniel He

Auto-generated profile, based on publicly available information

Daniel He

Department of Medicine, Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
ALAmy H Lee
Amy H Lee
CSCasey P Shannon
Casey P Shannon
NANelly Amenyogbe
Nelly Amenyogbe
Tue Bjerg BennikeTue Bjerg Bennike
Tue Bjerg Bennike
JAJoann Arce
Joann Arce
TKTobias R. Kollmann
Tobias R. Kollmann
Systems biology can unravel complex biology but has not been extensively applied to human newborns, a group highly vulnerable to a wide range of diseases. We optimized methods to extract transcriptomic, proteomic, metabolomic, cytokine/chemokine, and single cell immune phenotyping data from <1 ml of blood, a volume readily obtained from newborns. Indexing to baseline and applying innovative integrative computational methods reveals dramatic changes along a remarkably stable developmental trajectory over the first week of life. This is most evident in changes of interferon and complement pathways, as well as neutrophil-associated signaling. Validated across two independent cohorts of newborns from West Africa and Australasia, a robust and common trajectory emerges, suggesting a purposeful rather than random developmental path. Systems biology and innovative data integration can provide fresh insights into the molecular ontogeny of the first week of life, a dynamic developmental phase that is key for health and disease.

6 May 2020 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
BBByron Brook
Byron Brook
DHDanny J. Harbeson
Danny J. Harbeson
CSCasey P. Shannon
Casey P. Shannon
BCBing Cai
Bing Cai
DHDaniel He
Daniel He
NANelly Amenyogbe
Nelly Amenyogbe
Neonatal administration of BCG vaccine rapidly increases neutrophil production to reduce mortality from sepsis.

1 January 2015 in Development
Verified
Journal Article
Open access
PDF file
JAJeffrey M. Alexander
Jeffrey M. Alexander
SHSwetansu K. Hota
Swetansu K. Hota
DHDaniel He
Daniel He
STSean Thomas
Sean Thomas
LHLena Ho
Lena Ho
BBBenoit G. Bruneau
Benoit G. Bruneau
The interplay between different levels of gene regulation in modulating developmental transcriptional programs, such as histone modifications and chromatin remodeling, is not well understood. Here, we show that the chromatin remodeling factor Brg1 is required for enhancer activation in mesoderm induction. In an embryonic stem cell-based directed differentiation assay, the absence of Brg1 results in a failure of cardiomyocyte differentiation and broad deregulation of lineage-specific gene expression during mesoderm induction. We find that Brg1 co-localizes with H3K27ac at distal enhancers and is required for robust H3K27 acetylation at distal enhancers that are activated during mesoderm induction. Brg1 is also required to maintain Polycomb-mediated repression of non-mesodermal developmental regulators, suggesting cooperativity between Brg1 and Polycomb complexes. Thus, Brg1 is essential for modulating active and repressive chromatin states during mesoderm lineage commitment, in particular the activation of developmentally important enhancers. These findings demonstrate interplay between chromatin remodeling complexes and histone modifications that, together, ensure robust and broad gene regulation during crucial lineage commitment decisions.

29 May 2014 in Cell Cycle
Verified
Journal Article
Closed access
HCHelen Chen
Helen Chen
PMPooja Mohan
Pooja Mohan
JJJihong Jiang
Jihong Jiang
ONOksana Nemirovsky
Oksana Nemirovsky
DHDaniel He
Daniel He
CMChristopher Maxwell
Christopher Maxwell
Construction of a mitotic spindle requires biochemical pathways to assemble spindle microtubules and structural proteins to organize these microtubules into a bipolar array. Through a complex with ...

21 November 2019 in Allergy, Asthma & Clinical Immunology
Verified
Journal Article
Open access
PDF file
DHDaniel He
Daniel He
CYChen Xi Yang
Chen Xi Yang
BSBasak Sahin
Basak Sahin
ASAmrit Singh
Amrit Singh
CSCasey P. Shannon
Casey P. Shannon
STScott J. Tebbutt
Scott J. Tebbutt
Background: Blood has proven to be a useful resource for molecular analysis in numerous biomedical studies, with peripheral blood mononuclear cells (PBMCs) and whole blood being the major specimen types. However, comparative analyses between these two major compartments (PBMCs and whole blood) are few and far between. In this study, we compared gene expression profiles of PBMCs and whole blood samples obtained from research subjects with or without mild allergic asthma. Methods: Whole blood (PAXgene) and PBMC samples were obtained from 5 mild allergic asthmatics and 5 healthy controls. RNA from both sample types was measured for expression of 730 immune-related genes using the NanoString nCounter platform. Results: We identified 64 uniquely expressed transcripts in whole blood that reflected a variety of innate, humoral, and adaptive immune processes, and 13 uniquely expressed transcripts in PBMCs which were representative of T-cell and monocyte-mediated processes. Furthermore, analysis of mild allergic asthmatics versus non-asthmatics revealed 47 differentially expressed transcripts in whole blood compared to 1 differentially expressed transcript in PBMCs (FDR < 0.25). Finally, through simultaneous measurement of PBMC proteins on the nCounter assay, we identified CD28 and OX40 (TNFRSF4), both of which are critical co-stimulatory molecules during T-cell activation, as significantly upregulated in asthmatics. Conclusions: Whole blood RNA preserved in PAXgene tubes is excellent for producing gene expression data with minimal variability and good sensitivity, suggesting its utility in multi-centre studies requiring measurement of blood gene expression.

27 November 2024 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
DHDaniel He
Daniel He
GSGuler Sabina
Guler Sabina
CSCasey P. Shannon
Casey P. Shannon
CRChristopher J. Ryerson
Christopher J. Ryerson
STScott J. Tebbutt
Scott J. Tebbutt
Objective Gene expression (transcriptomics) studies have revealed potential mechanisms of interstitial lung disease (ILD), yet sample sizes of studies are often limited and between-subtype comparisons are scarce. The aim of this study was to identify and validate consensus transcriptomic signatures of ILD subtypes. Methods We performed a systematic review and meta-analysis of fibrotic ILD transcriptomics studies using an individual participant data approach, and included studies examining bulk transcriptomics of human adult ILD samples and excluding those focusing on individual cell populations. Patient-level data and expression matrices were extracted from 43 studies and integrated using a multivariable integrative algorithm to develop ILD classification models. Results Using 1459 samples from 24 studies, we identified transcriptomic signatures for idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis (HP), idiopathic nonspecific interstitial pneumonia (NSIP), and systemic sclerosis-associated ILD (SSc-ILD) against control samples, which were validated on 308 samples from 8 studies (area under receiver operating curve [AUC]=0.99 [95% CI: 0.99–1.00], HP AUC=0.91 [0.84–0.99], NSIP AUC=0.94 [0.88–0.99], SSc-ILD AUC=0.98 [0.93–1.00]). Significantly, meta-analysis allowed, for the first time, identification of robust lung transcriptomics signatures to discriminate IPF (AUC=0.71 [0.63–0.79]) and HP (AUC=0.76 [0.63–0.89]) from other fibrotic ILDs, and unsupervised learning algorithms identified putative molecular endotypes of ILD associated with decreased forced vital capacity (FVC) and diffusing capacity of the lungs for carbon monoxide (DLCO) % predicted. Transcriptomics signatures were reflective of both cell-specific and disease-specific changes in gene expression. Conclusion We present the first systematic review and largest meta-analysis of fibrotic ILD transcriptomics to date, identifying reproducible transcriptomic signatures with clinical relevance.